181 related articles for article (PubMed ID: 4003296)
1. RO13-6438, a new inotrope-vasodilator: systemic and coronary hemodynamic effects in congestive heart failure.
Daly PA; Chatterjee K; Viquerat CE; Parmley WW; Curran D; Scheinbaum M; Anderson S
Am J Cardiol; 1985 Jun; 55(13 Pt 1):1539-44. PubMed ID: 4003296
[TBL] [Abstract][Full Text] [Related]
2. Alterations in left ventricular function, coronary hemodynamics and myocardial catecholamine balance with MDL 17043, a new inotropic vasodilator agent, in patients with severe heart failure.
Viquerat CE; Kereiakes D; Morris DL; Daly PA; Wexman M; Frank P; Parmley WW; Chatterjee K
J Am Coll Cardiol; 1985 Feb; 5(2 Pt 1):326-32. PubMed ID: 3155761
[TBL] [Abstract][Full Text] [Related]
3. Effects of milrinone on coronary hemodynamics and myocardial energetics in patients with congestive heart failure.
Monrad ES; Baim DS; Smith HS; Lanoue A; Brauwald E; Grossman W
Circulation; 1985 May; 71(5):972-9. PubMed ID: 3986984
[TBL] [Abstract][Full Text] [Related]
4. Cardiocirculatory effects of afterload reduction with oral trimazosin in severe chronic congestive heart failure.
Awan NA; Hermanovich J; Whitcomb C; Skinner P; Mason DT
Am J Cardiol; 1979 Jul; 44(1):126-31. PubMed ID: 453037
[TBL] [Abstract][Full Text] [Related]
5. Flosequinan, a new vasodilator: systemic and coronary hemodynamics and neuroendocrine effects in congestive heart failure.
Cavero PG; De Marco T; Kwasman M; Lau D; Liu M; Chatterjee K
J Am Coll Cardiol; 1992 Dec; 20(7):1542-8. PubMed ID: 1452928
[TBL] [Abstract][Full Text] [Related]
6. Hemodynamic and metabolic effects of isosorbide dinitrate in chronic congestive heart failure.
Gray R; Chatterjee K; Vyden JK; Ganz W; Forrester JS; Swan HJ
Am Heart J; 1975 Sep; 90(3):346-52. PubMed ID: 1163426
[TBL] [Abstract][Full Text] [Related]
7. Hemodynamic and clinical evaluation of piroximone, a new inotrope-vasodilator agent, in severe congestive heart failure.
Axelrod RJ; De Marco T; Dae M; Botvinick EH; Chatterjee K
J Am Coll Cardiol; 1987 May; 9(5):1124-30. PubMed ID: 3571752
[TBL] [Abstract][Full Text] [Related]
8. Myocardial energetics and clinical response to the cardiotonic agent MDL 17043 in advanced heart failure.
Martin JL; Likoff MJ; Janicki JS; Laskey WK; Hirshfeld JW; Weber KT
J Am Coll Cardiol; 1984 Nov; 4(5):875-83. PubMed ID: 6238075
[TBL] [Abstract][Full Text] [Related]
9. Coronary hemodynamic effects of angiotensin inhibition by captopril and teprotide in patients with congestive heart failure.
Halperin JL; Faxon DP; Creager MA; Bass TA; Melidossian CD; Gavras H; Ryan TJ
Am J Cardiol; 1982 Nov; 50(5):967-72. PubMed ID: 6182786
[TBL] [Abstract][Full Text] [Related]
10. Intravenous and oral MDL 17043 (a new inotrope-vasodilator agent) in congestive heart failure: hemodynamic and clinical evaluation in 38 patients.
Kereiakes D; Chatterjee K; Parmley WW; Atherton B; Curran D; Kereiakes A; Spangenberg R
J Am Coll Cardiol; 1984 Nov; 4(5):884-9. PubMed ID: 6238076
[TBL] [Abstract][Full Text] [Related]
11. Acute effects of oral pirbuterol on myocardial oxygen metabolism and systemic hemodynamics in chronic congestive heart failure.
Rude RE; Turi Z; Brown EJ; Lorell BH; Colucci WS; Mudge GH; Taylor CR; Grossman W
Circulation; 1981 Jul; 64(1):139-45. PubMed ID: 7237712
[TBL] [Abstract][Full Text] [Related]
12. Arterial vasodilator, systemic and coronary hemodynamic effects of nisoldipine in congestive heart failure secondary to ischemic or dilated cardiomyopathy.
Kiowski W; Erne P; Pfisterer M; Mueller J; Buehler FR; Burkart F
Am J Cardiol; 1987 May; 59(12):1118-25. PubMed ID: 3578053
[TBL] [Abstract][Full Text] [Related]
13. Systemic and coronary hemodynamic and neurohumoral effects of levodopa in chronic congestive heart failure.
De Marco T; Daly PA; Chatterjee K
Am J Cardiol; 1988 Dec; 62(17):1228-33. PubMed ID: 2904216
[TBL] [Abstract][Full Text] [Related]
14. Intravenous and oral prenalterol in congestive heart failure. Effects on systemic and coronary hemodynamics and myocardial catecholamine balance.
Wahr DW; Swedberg K; Rabbino M; Hoyle MJ; Curran D; Parmley WW; Chatterjee K
Am J Med; 1984 Jun; 76(6):999-1005. PubMed ID: 6731471
[TBL] [Abstract][Full Text] [Related]
15. Effects of amrinone on myocardial energy metabolism and hemodynamics in patients with severe congestive heart failure due to coronary artery disease.
Benotti JR; Grossman W; Braunwald E; Carabello BA
Circulation; 1980 Jul; 62(1):28-34. PubMed ID: 7379283
[TBL] [Abstract][Full Text] [Related]
16. Hemodynamic and metabolic effects of vasodilator therapy for heart failure in acute myocardial infarction.
Kodama K; Koretsune Y; Nanto S; Taniura K
Jpn Circ J; 1984 Apr; 48(4):380-7. PubMed ID: 6425527
[TBL] [Abstract][Full Text] [Related]
17. Acute hemodynamic effect of oral MDL 17,043 in severe congestive heart failure.
Uretsky BF; Generalovich T; Reddy PS; Salerni R; Valdes AM; Spangenberg RB; Lang JF; Okerholm RA
Am J Cardiol; 1984 Aug; 54(3):357-62. PubMed ID: 6235735
[TBL] [Abstract][Full Text] [Related]
18. Clinical use of sodium nitroprusside in chronic ischemic heart disease. Effects on peripheral vascular resistance and venous tone and on ventricular volume, pump and mechanical performance.
Miller RR; Vismara LA; Zelis R; Amsterdam EA; Mason DT
Circulation; 1975 Feb; 51(2):328-36. PubMed ID: 1112013
[TBL] [Abstract][Full Text] [Related]
19. Improved hemodynamic function and mechanical efficiency in congestive heart failure with sodium dichloroacetate.
Bersin RM; Wolfe C; Kwasman M; Lau D; Klinski C; Tanaka K; Khorrami P; Henderson GN; de Marco T; Chatterjee K
J Am Coll Cardiol; 1994 Jun; 23(7):1617-24. PubMed ID: 8195522
[TBL] [Abstract][Full Text] [Related]
20. Effects of hydralazine on coronary blood flow and myocardial energetics in congestive heart failure.
Magorien RD; Brown GP; Unverferth DV; Nelson S; Boudoulas H; Bambach D; Leier CV
Circulation; 1982 Mar; 65(3):528-33. PubMed ID: 7055874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
